Lanreotide as Treatment of Polycystic Livers

Clinical trial NCT00565097 · COMPLETED

Trial details

NCT number: NCT00565097
Sponsor: Radboud University Medical Center
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Polycystic Liver Disease Hepatomegaly Liver Diseases Polycystic Kidney, Autosomal Dominant

Start date: 2007-10-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.